Navis Capital-backed Vietnamese drug producer OPV Pharmaceuticals JSC is said to be on the block with its shareholders targeting a 100% share sale, DealStreetAsia has learned.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
